Cargando…

Plasma xanthine oxidoreductase activity in patients with decompensated acute heart failure requiring intensive care

AIMS: Plasma xanthine oxidoreductase (XOR) activity during the acute phase of acute heart failure (AHF) requires further elucidation. METHODS AND RESULTS: One hundred eighteen AHF patients and 231 control patients who attended a cardiovascular outpatient clinic were prospectively analysed. Blood sam...

Descripción completa

Detalles Bibliográficos
Autores principales:	Okazaki, Hirotake, Shirakabe, Akihiro, Matsushita, Masato, Shibata, Yusaku, Sawatani, Tomofumi, Uchiyama, Saori, Tani, Kennichi, Murase, Takayo, Nakamura, Takashi, Takayasu, Tsutomu, Asano, Miwako, Kobayashi, Nobuaki, Hata, Noritake, Asai, Kuniya, Shimizu, Wataru
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Original Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6437423/ https://www.ncbi.nlm.nih.gov/pubmed/30620450 http://dx.doi.org/10.1002/ehf2.12390

Ejemplares similares

Time‐dependent changes in plasma xanthine oxidoreductase during hospitalization of acute heart failure
por: Okazaki, Hirotake, et al.
Publicado: (2020)

Plasma Xanthine Oxidoreductase (XOR) Activity in Cardiovascular Disease Outpatients
por: Matsushita, Masato, et al.
Publicado: (2020)

Worsening renal failure in patients with acute heart failure: the importance of cardiac biomarkers
por: Shirakabe, Akihiro, et al.
Publicado: (2019)

Hyperuricemia complicated with acute kidney injury is associated with adverse outcomes in patients with severely decompensated acute heart failure()
por: Shirakabe, Akihiro, et al.
Publicado: (2019)

Gender Differences in the Social Determinants of the Long-term Prognosis for Severely Decompensated Acute Heart Failure in Patients over 75 Years of Age
por: Matsushita, Masato, et al.
Publicado: (2019)

Clinical Features of Acute Heart Failure During Sleep　― Prognostic Impact of a Prodrome in Patients With Severely Decompensated Acute Heart Failure Admitted at Midnight or Early Morning ―
por: Matsushita, Masato, et al.
Publicado: (2019)

Prognostic Value of Both Plasma Volume Status and Nutritional Status in Patients With Severely Decompensated Acute Heart Failure
por: Shirakabe, Akihiro, et al.
Publicado: (2019)

Worsening renal function definition is insufficient for evaluating acute renal failure in acute heart failure
por: Shirakabe, Akihiro, et al.
Publicado: (2018)

Importance of the Corrected Calcium Level in Patients With Acute Heart Failure Requiring Intensive Care
por: Shirakabe, Akihiro, et al.
Publicado: (2020)

Clinical Significance of Low-Triiodothyronine Syndrome in Patients Requiring Non-Surgical Intensive Care　― Triiodothyronine Is a Comprehensive Prognostic Marker for Critical Patients With Cardiovascular Disease ―
por: Shigihara, Shota, et al.
Publicado: (2021)

Successful Treatment of Thrombocytopenia, Anasarca, Fever, Reticulin Myelofibrosis/Renal Insufficiency, and Organomegaly Syndrome Using Plasma Exchange Followed by Rituximab in the Intensive Care Unit
por: Otsuka, Yusuke, et al.
Publicado: (2021)

Clinical Approach to Shortening Length of Hospital Stay in Elderly Patients With Acute Heart Failure Requiring Intensive Care
por: Shirakabe, Akihiro, et al.
Publicado: (2020)

Xanthine oxidoreductase activity is correlated with hepatic steatosis
por: Yagi, Chisako, et al.
Publicado: (2022)

Influence of xanthine oxidoreductase inhibitor, topiroxostat, on body weight of diabetic obese mice
por: Nakamura, Takashi, et al.
Publicado: (2021)

Relationship between Xanthine Oxidoreductase Redox and Oxidative Stress among Chronic Kidney Disease Patients
por: Terawaki, Hiroyuki, et al.
Publicado: (2018)

Type III procollagen peptide level can indicate liver dysfunction associated with volume overload in acute heart failure
por: Shirakabe, Akihiro, et al.
Publicado: (2022)

Independent links between plasma xanthine oxidoreductase activity and levels of adipokines
por: Furuhashi, Masato, et al.
Publicado: (2019)

Gender Differences in the Impact of Plasma Xanthine Oxidoreductase Activity on Coronary Artery Spasm
por: Watanabe, Ken, et al.
Publicado: (2021)

Diurnal Variations in Serum Uric Acid, Xanthine, and Xanthine Oxidoreductase Activity in Male Patients with Coronary Artery Disease
por: Shimizu, Megumi, et al.
Publicado: (2023)

Impact of Plasma Xanthine Oxidoreductase Activity on the Mechanisms of Distal Symmetric Polyneuropathy Development in Patients with Type 2 Diabetes
por: Fujishiro, Midori, et al.
Publicado: (2021)

Habitual exercise decreases plasma xanthine oxidoreductase activity in middle-aged and older women
por: Kosaki, Keisei, et al.
Publicado: (2018)

Empagliflozin Administration Can Decrease the Dose of Loop Diuretics and Prevent the Exacerbation of Renal Tubular Injury in Patients With Compensated Heart Failure Complicated by Diabetes
por: Shirakabe, Akihiro, et al.
Publicado: (2020)

Xanthine oxidoreductase activity is associated with serum uric acid and glycemic control in hemodialysis patients
por: Nakatani, Ayumi, et al.
Publicado: (2017)

Impact of plasma xanthine oxidoreductase activity in patients with heart failure with preserved ejection fraction
por: Watanabe, Ken, et al.
Publicado: (2020)

Association of the plasma xanthine oxidoreductase activity with the metabolic parameters and vascular complications in patients with type 2 diabetes
por: Okuyama, Tomoko, et al.
Publicado: (2021)

Organ dysfunction, injury, and failure in cardiogenic shock
por: Shirakabe, Akihiro, et al.
Publicado: (2023)

The serum heart-type fatty acid-binding protein (HFABP) levels can be used to detect the presence of acute kidney injury on admission in patients admitted to the non-surgical intensive care unit
por: Shirakabe, Akihiro, et al.
Publicado: (2016)

Possible role of insulin resistance in activation of plasma xanthine oxidoreductase in health check-up examinees
por: Kurajoh, Masafumi, et al.
Publicado: (2022)

A Newly Developed Method-Based Xanthine Oxidoreductase Activities in Various Human Liver Diseases
por: Sato, Ken, et al.
Publicado: (2023)

Relationship between plasma xanthine oxidoreductase activity and left ventricular ejection fraction and hypertrophy among cardiac patients
por: Fujimura, Yuki, et al.
Publicado: (2017)

Systemic Endothelial Function, Plasma Xanthine Oxidoreductase Activity, and Blood Pressure Variability in Patients with Stable Coronary Artery Disease
por: Hiraga, Takashi, et al.
Publicado: (2022)

Plasma xanthine oxidoreductase activity in Japanese patients with type 2 diabetes across hospitalized treatment
por: Kawachi, Yusuke, et al.
Publicado: (2020)

Association of plasma xanthine oxidoreductase activity with blood pressure affected by oxidative stress level: MedCity21 health examination registry
por: Yoshida, Shio, et al.
Publicado: (2020)

Successful treatment of a patient with type-A acute aortic dissection with emergent percutaneous coronary intervention and thoracic endovascular aortic repair under percutaneous cardiopulmonary support: a case report
por: Shigihara, Shota, et al.
Publicado: (2022)

Association between plasma xanthine oxidoreductase activity and in-hospital outcomes in patients with stable coronary artery disease after percutaneous coronary intervention
por: Sato, Ryota, et al.
Publicado: (2021)

Associations of circulating xanthine oxidoreductase activity with cardiometabolic risk markers in overweight and obese Japanese men: a cross-sectional pilot study
por: Kosaki, Keisei, et al.
Publicado: (2022)

Pro-Aging Effects of Xanthine Oxidoreductase Products
por: Battelli, Maria Giulia, et al.
Publicado: (2020)

Discriminating Susceptibility of Xanthine Oxidoreductase Family to Metals
por: Steunou, Anne-Soisig, et al.
Publicado: (2023)

Metabolic syndrome and cancer risk: The role of xanthine oxidoreductase
por: Battelli, Maria Giulia, et al.
Publicado: (2018)

Xanthine oxidoreductase: One enzyme for multiple physiological tasks
por: Bortolotti, Massimo, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_jmu4fb7hmquhpjce6ogj1mug8o